Barings LLC Johnson & Johnson Transaction History

Barings LLC

$3.9 Billion
Q2 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	BUY	$155.22 - $162.74 $212,651 - $222,953	1,370 New	1,370 $216,000
Q3 2023 Nov 13, 2023	SELL	$155.75 - $174.48 $101,393 - $113,586	-651 Reduced 32.78%	1,335 $207,000
Q2 2023 Aug 08, 2023	BUY	$154.35 - $166.11 $51,398 - $55,314	333 Added 20.15%	1,986 $328,000
Q1 2023 May 09, 2023	SELL	$151.05 - $180.26 $600,876 - $717,074	-3,978 Reduced 70.64%	1,653 $256,000
Q4 2022 Feb 13, 2023	SELL	$160.2 - $179.79 $105,411 - $118,301	-658 Reduced 10.46%	5,631 $994,000
Q3 2022 Nov 14, 2022	SELL	$161.33 - $179.52 $2.31 Million - $2.57 Million	-14,332 Reduced 69.5%	6,289 $1.03 Million
Q2 2022 Aug 08, 2022	BUY	$168.19 - $186.01 $1.07 Million - $1.18 Million	6,353 Added 44.53%	20,621 $3.66 Million
Q1 2022 May 13, 2022	SELL	$158.14 - $179.59 $605,518 - $687,650	-3,829 Reduced 21.16%	14,268 $2.53 Million
Q4 2021 Feb 09, 2022	BUY	$155.93 - $173.01 $96,676 - $107,266	620 Added 3.55%	18,097 $3.1 Million
Q3 2021 Nov 12, 2021	BUY	$161.5 - $179.47 $1.34 Million - $1.49 Million	8,299 Added 90.42%	17,477 $2.82 Million
Q2 2021 Aug 11, 2021	SELL	$159.48 - $171.07 $163,945 - $175,859	-1,028 Reduced 10.07%	9,178 $1.51 Million
Q1 2021 May 11, 2021	SELL	$153.07 - $170.48 $481,252 - $535,989	-3,144 Reduced 23.55%	10,206 $1.68 Million
Q4 2020 Feb 16, 2021	SELL	$137.11 - $157.38 $10.8 Million - $12.4 Million	-78,689 Reduced 85.5%	13,350 $2.1 Million
Q3 2020 Nov 12, 2020	SELL	$140.38 - $153.83 $1.31 Million - $1.44 Million	-9,339 Reduced 9.21%	92,039 $13.7 Million
Q1 2020 May 15, 2020	BUY	$111.14 - $153.99 $161,930 - $224,363	1,457 Added 1.46%	101,378 $13.3 Million
Q4 2019 Feb 14, 2020	SELL	$127.5 - $146.44 $2.43 Million - $2.79 Million	-19,044 Reduced 16.01%	99,921 $14.6 Million
Q3 2019 Nov 13, 2019	SELL	$126.95 - $142.14 $6,093 - $6,822	-48 Reduced 0.04%	118,965 $15.4 Million
Q2 2019 Aug 12, 2019	BUY	$131.15 - $144.24 $4.17 Million - $4.59 Million	31,801 Added 36.46%	119,013 $16.6 Million
Q1 2019 May 08, 2019	SELL	$125.72 - $139.79 $576,300 - $640,797	-4,584 Reduced 4.99%	87,212 $12.2 Million
Q4 2018 Feb 07, 2019	SELL	$122.84 - $147.84 $5.47 Million - $6.58 Million	-44,512 Reduced 32.66%	91,796 $11.8 Million
Q3 2018 Oct 26, 2018	BUY	$121.58 - $142.88 $2.08 Million - $2.44 Million	17,106 Added 14.35%	136,308 $18.8 Million
Q2 2018 Aug 03, 2018	SELL	$119.4 - $131.76 $315,096 - $347,714	-2,639 Reduced 2.17%	119,202 $14.5 Million
Q1 2018 May 04, 2018	SELL	$125.1 - $148.14 $863,190 - $1.02 Million	-6,900 Reduced 5.36%	121,841 $15.6 Million
Q4 2017 Feb 08, 2018	BUY	$131.22 - $143.62 $3.68 Million - $4.03 Million	28,030 Added 27.83%	128,741 $18 Million
Q3 2017 Nov 13, 2017	SELL	$129.47 - $135.38 $1.51 Million - $1.58 Million	-11,640 Reduced 10.36%	100,711 $13.1 Million
Q2 2017 Aug 15, 2017	SELL	N/A	-77,152 Reduced 40.71%	112,351 $14.9 Million
Q2 2017 Aug 14, 2017	BUY	N/A	189,503	189,503 $0

Others Institutions Holding JNJ

# of Institutions

4,227

Shares Held

1.7B

Call Options Held

12.5M

Put Options Held

10.3M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $410B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barings LLC, based on Form 13F filings with the SEC.

News

Stay updated on Barings LLC with notifications on news.

Account